首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷超音波

市場調查報告書

商品編碼

1500140

血管內支架市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、產品、最終用途、地區和競爭細分，2019-2029F

Intravascular Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End-Use, By Region and Competition, 2019-2029F

出版日期: 2024年06月21日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球血管內支架市場估值為119.8億美元，預計在預測期內穩定成長，到2029年複合年成長率為7.30%。人體內的血管，通常是動脈或靜脈。它們用於稱為血管成形術的醫療程序，這是一種微創技術，用於治療各種血管疾病，特別是與動脈粥狀硬化和動脈狹窄相關的疾病。血管內支架有助於恢復血管中的正常血流並預防與血管阻塞相關的併發症。血管內支架主要用於治療血管疾病，最常見於冠狀動脈（冠狀動脈支架）和周邊動脈（周邊支架），但也可用於全身其他血管。支架通常是由生物相容性材料製成的管狀網狀結構，例如不銹鋼、鈷鉻合金、鎳鈦合金（鎳鈦諾）或生物可吸收聚合物。它們可以是裸露的金屬，也可以塗有藥物洗脫塗層。在血管成形術過程中將支架放置在受影響的血管內。首先，將尖端有放氣氣球的導管穿入阻塞或狹窄的血管中。球囊膨脹，將斑塊或阻塞壓縮到血管壁上，恢復血流。然後，安裝在球囊上的支架膨脹，充當支架以保持血管開放。

市場概況
預測期	2025-2029
2023 年市場規模	119.8億美元
2029 年市場規模	182億美元
2024-2029 年複合年成長率	7.30%
成長最快的細分市場	醫院和診所
最大的市場	北美洲

全球老化人口更容易罹患心血管疾病。隨著老年人口的增加，對血管內支架的需求也增加。支架設計、材料和塗層的持續研究和創新促進了更有效、更安全的支架的開發，從而推動了市場成長。人們對心血管健康的認知提高，診斷技術提高，定期健康檢查可以更早發現心血管疾病，從而導致更多的支架手術。久坐的生活方式、不良的飲食習慣和壓力增加等因素導致心血管疾病的發生率上升，從而增加了對支架的需求。人們越來越重視追蹤患者的治療結果和現實世界的證據，以確定不同支架類型和材料的有效性，這正在推動創新。

主要市場促進因素

技術進步

提高認知和診斷

人口老化加劇

主要市場挑戰

上市後監督和報告

市場飽和

主要市場趨勢

客製化和個人化

細分市場洞察

類型洞察

產品洞察

區域洞察

Global Intravascular Stents Market was valued at USD 11.98 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 7.30% through 2029. Intravascular stents are medical devices designed to support and maintain the patency (openness) of blood vessels, typically arteries or veins, within the human body. They are used in a medical procedure called angioplasty, which is a minimally invasive technique for treating various vascular conditions, especially those related to atherosclerosis and arterial narrowing. Intravascular stents are instrumental in restoring proper blood flow through vessels and preventing complications associated with vascular blockages. Intravascular stents are primarily used to treat vascular conditions, most commonly in the coronary arteries (coronary stents) and peripheral arteries (peripheral stents), but they can also be used in other vessels throughout the body. Stents are typically tubular, mesh-like structures made from biocompatible materials, such as stainless steel, cobalt-chromium alloys, nickel-titanium (Nitinol), or bioresorbable polymers. They can be bare metal or coated with drug-eluting coatings. Stents are placed inside the affected blood vessel during an angioplasty procedure. First, a catheter with a deflated balloon at its tip is threaded into the blocked or narrowed vessel. The balloon is inflated to compress the plaque or obstruction against the vessel wall, restoring blood flow. Then, the stent, which is mounted on the balloon, is expanded to act as a scaffold to keep the vessel open.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 11.98 Billion
Market Size 2029	USD 18.20 Billion
CAGR 2024-2029	7.30%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America

The global aging population is more prone to cardiovascular diseases. As the elderly population increases, so does the demand for intravascular stents. Ongoing research and innovation in stent design, materials, and coatings lead to the development of more effective and safer stents, which drive market growth. Greater awareness of cardiovascular health improved diagnostic techniques, and regular health screenings have led to earlier detection of cardiovascular conditions, resulting in more stent procedures. Factors such as sedentary lifestyles, poor dietary habits, and increased stress contribute to the rising incidence of cardiovascular diseases, boosting the demand for stents. An increasing emphasis on tracking patient outcomes and real-world evidence to determine the effectiveness of different stent types and materials is driving innovation.

Key Market Drivers

Technological Advancements

Drug-eluting stents are coated with medications that are slowly released to inhibit tissue regrowth and reduce restenosis (re-narrowing of the treated vessel). The development of various drug coatings, such as sirolimus and paclitaxel, has significantly improved the long-term efficacy of stents in preventing restenosis. Bioabsorbable stents are designed to gradually dissolve in the body over time, leaving behind only natural tissue. These stents eliminate some of the long-term issues associated with metallic stents, such as the risk of late stent thrombosis and potential interference with future procedures or imaging.

Hybrid stent designs combine the benefits of both balloon-expandable and self-expanding stents. These stents provide precise deployment and radial strength while also adapting to vessel anatomy. Some DES now use bioresorbable polymer coatings to release drugs. These coatings are absorbed by the body over time, reducing the risk of chronic inflammation and long-term complications. 3D printing technology is being used to create patient-specific stents tailored to an individual's unique vascular anatomy. This can lead to more effective and personalized treatment. Nanotechnology is being employed to improve the biocompatibility of stents, allowing for better integration with vascular tissue and reduced inflammation. Radiopaque stents are designed to be highly visible under fluoroscopy, aiding in precise placement. Radiolucent stents are transparent under X-ray, enabling better visualization of vessel structures. Advancements in coating technologies, such as nano-coatings and bioactive coatings, enhance the release of drugs and improve stent performance.

Reducing the thickness of stent struts minimizes the obstruction to blood flow, reduces the risk of restenosis, and improves deliverability during the procedure. These stents use biodegradable polymers that are gradually absorbed by the body. This technology minimizes long-term inflammation and complications associated with polymer coatings. Innovations in imaging and 3D modeling allow for the creation of stents that precisely match a patient's vascular anatomy, reducing complications and optimizing treatment. These devices combine angioplasty balloons with drug coatings to provide localized drug delivery to the treated area. They are used in conjunction with stents or as an alternative treatment option. The use of advanced materials and alloys, such as nitinol, in stent construction allows for improved flexibility, conformability, and durability. Stent manufacturers are exploring the integration of sensors into stents, enabling remote monitoring of stent performance and patient condition. This factor will help in the development of the Global Intravascular Stents Market.

Increasing Awareness and Diagnosis

Greater awareness of cardiovascular health and the availability of routine screenings and diagnostic tests have led to the early detection of cardiovascular conditions. This includes coronary artery disease, peripheral artery disease, and other vascular disorders that may require stent implantation. With improved awareness, individuals at risk of cardiovascular diseases are more likely to seek medical attention when they experience symptoms or risk factors. Early intervention can prevent disease progression and may involve the use of intravascular stents.

Timely diagnosis and treatment can reduce the severity of the disease, lower the risk of complications, and improve patient outcomes. Stent placement is often a minimally invasive and effective solution for managing these conditions. Increased awareness often leads to better patient education about cardiovascular diseases and available treatment options, including stent placement. Informed patients are more likely to participate in their healthcare decisions. Awareness campaigns and improved public knowledge about cardiovascular diseases lead to more referrals from primary care physicians and general practitioners to specialists who may recommend stent procedures when appropriate. Increased awareness encourages individuals to manage modifiable risk factors, such as smoking, unhealthy diet, and sedentary lifestyles, which can contribute to the prevention of cardiovascular diseases and reduce the need for stent interventions.

National and regional health organizations often run screening programs and campaigns that target at-risk populations. These programs lead to increased diagnosis and may result in the use of stents as a treatment option. Global health initiatives, including World Heart Day and World Stroke Day, play a role in raising awareness about the burden of cardiovascular diseases, promoting prevention, and encouraging timely treatment when necessary. Local health departments, clinics, and healthcare organizations often engage in community outreach efforts to educate the public about heart health and the importance of early diagnosis and treatment. Awareness efforts also help reduce the stigma associated with cardiovascular diseases, making it more acceptable for individuals to discuss symptoms and seek treatment. A growing focus on cardiovascular health has led to increased research and innovation in the field of intravascular stents, resulting in more effective and safer stent designs and technologies. This factor will pace up the demand of the Global Intravascular Stents Market.

Increasing Aging Population

As individuals age, their risk of developing cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and aortic stenosis, significantly increases. These conditions often require the use of intravascular stents for treatment. Older adults are more likely to have chronic health conditions, such as diabetes, hypertension, and hyperlipidemia, which are risk factors for cardiovascular diseases. These conditions may necessitate the use of stents to manage and treat vascular complications. The aging process is associated with changes in blood vessels, such as atherosclerosis and arterial stiffening, which can lead to vascular obstructions. Stents are commonly used to address these age-related changes. Older patients often have complex medical histories, including prior cardiovascular interventions or comorbid conditions, making stent procedures a valuable treatment option to manage their healthcare needs.

Advances in healthcare and medical treatments have increased life expectancy, resulting in a larger aging population. As individuals live longer, they are more likely to experience age-related cardiovascular issues that may require stent interventions. Older adults are increasingly considered surgical candidates for stent procedures, as advancements in healthcare allow for improved outcomes and safety for elderly patients. The elderly population often prefers minimally invasive procedures like stent placement, as they typically involve shorter recovery times and reduced trauma compared to open surgeries. Aging patients may undergo stent procedures as preventive interventions to address potential blockages or stenoses in their arteries before they lead to severe complications.

Stent placement can allow older adults to maintain an active and independent lifestyle, reducing the impact of cardiovascular conditions on daily activities. Older individuals, particularly in developed countries, have better access to healthcare, including specialized cardiology services that offer stent procedures. The aging population benefits from post-stent care, which helps manage their cardiovascular health and reduce the risk of complications or revascularization procedures. With longer life expectancies, older patients are more inclined to educate themselves about cardiovascular health and the available treatment options, including stent procedures. This factor will accelerate the demand of the Global Intravascular Stents Market.

Key Market Challenges

Post-Market Surveillance and Reporting

The need for long-term follow-up data to assess the safety and efficacy of intravascular stents is a considerable challenge. Stents are implanted for extended periods, and adverse events or complications may not become evident until years after the procedure. The intravascular stents market serves diverse patient populations with varying risk factors, comorbidities, and anatomical characteristics. This diversity complicates data collection and analysis, making it challenging to draw broad conclusions about stent performance. There is variability in how adverse events and complications are reported and recorded among different healthcare institutions and regions. This can hinder the aggregation and analysis of post-market data. Adverse events associated with stent use may be underreported, either due to lack of awareness or reluctance on the part of healthcare providers or patients. This can lead to incomplete data and an inaccurate assessment of stent safety. Variations in regulatory requirements and post-market surveillance expectations in different countries or regions can complicate the harmonization of data collection and reporting practices. Collating and integrating data from various sources, including electronic health records, clinical studies, and device registries, can be technically challenging, especially in cases where healthcare systems lack interoperability. Stringent patient privacy regulations and concerns can limit the sharing of patient data across institutions and borders, hindering comprehensive post-market surveillance efforts.

Market Saturation

The global intravascular stents market is relatively mature, with a well-established presence of multiple manufacturers and a wide range of stent products. This maturity can limit opportunities for significant growth. Market saturation often leads to intense competition among stent manufacturers, resulting in pricing pressures and reduced profit margins. In mature markets, there may be less room for groundbreaking innovations, as many of the key technological advancements have already been introduced. This can limit opportunities for differentiation. Most healthcare facilities, especially in developed regions, are already equipped to perform stent procedures, and many physicians are experienced in stent implantation. This saturation limits the expansion of the customer base. As the market becomes saturated, the overall growth rate may slow down, making it challenging for companies to achieve substantial revenue increases. Fierce competition often leads to price competition, which can impact the profitability of stent manufacturers. Lower prices may be required to gain or maintain market share.

Key Market Trends

Customization and Personalization

Advancements in medical imaging, such as computed tomography (CT), angiography and intravascular ultrasound (IVUS), allow for the creation of patient-specific stents. These stents are designed to match the unique vascular anatomy of each patient, improving the precision and effectiveness of the intervention. 3D printing technology is being used to manufacture stents that are customized to fit individual patients. These stents are designed based on the specific dimensions and geometry of a patient's vessels, potentially reducing complications, and improving stent performance. Personalization extends to the choice of coatings and drugs used in drug-eluting stents (DES). Different patients may respond differently to various coatings and drugs, and the ability to customize these elements can optimize patient outcomes. Customized stent solutions align with the principles of precision medicine, where medical decisions and treatments are tailored to the genetic, molecular, and clinical characteristics of individual patients. Personalization in the intravascular stents market involves assessing an individual patient's risk factors, comorbidities, and specific cardiovascular conditions. This information helps guide stent selection and treatment decisions.

Segmental Insights

Type Insights

Based on Type, Drug Eluting Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Drug-eluting stents are designed to release drugs that inhibit tissue regrowth in the stented area, reducing the risk of restenosis (renarrowing of the vessel). As a result, DES have been shown to have superior clinical outcomes compared to bare-metal stents (BMS), with lower rates of restenosis and target lesion revascularization. Because of their ability to prevent restenosis, DES reduce the need for repeat procedures, such as angioplasty or additional stent implantation. This not only improves patient outcomes but also reduces the economic burden on healthcare systems. DES often have special coatings or drugs that help prevent the formation of blood clots (thrombosis) inside the stent, reducing the risk of in-stent thrombosis and its associated complications. DES are particularly effective in treating complex lesions, such as long and calcified blockages, which are challenging to address with BMS. This makes DES a preferred choice for many interventional procedures. The DES segment offers a wide array of choices, including various drug types (e.g., sirolimus, paclitaxel, zotarolimus) and stent designs, allowing healthcare providers to tailor the treatment to the patient's specific needs.

Product Insights

Based on Product, Coronary Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Coronary artery disease (CAD) is one of the most common cardiovascular diseases worldwide. It involves the narrowing or blockage of the coronary arteries that supply blood to the heart muscle. Given the high incidence of CAD, there is a substantial demand for coronary stents to treat this condition. Coronary stents are frequently used in life-threatening situations, such as heart attacks (myocardial infarctions) or unstable angina. These emergency situations require prompt intervention to restore blood flow to the heart muscle, and coronary stents play a critical role in this regard. Coronary stent implantation procedures, both elective and emergency, are well-established and widely practiced in cardiology. Physicians have extensive experience and training in performing these procedures, which contributes to their popularity. Clinical trials and studies have consistently shown the effectiveness of coronary stents in improving patient outcomes, reducing symptoms, and preventing complications associated with CAD, such as heart attacks. Continuous research and development efforts in the field of coronary stents have led to innovations in design, materials, and drug-eluting technologies, resulting in safer and more effective stents. These advancements enhance the appeal of coronary stents to both healthcare professionals and patients.

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Intravascular Stents Market in 2023. North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. This infrastructure includes state-of-the-art hospitals, well-equipped cardiac care centers, and many skilled healthcare professionals, which are essential for the diagnosis and treatment of cardiovascular diseases, often requiring intravascular stents. The region has a significant prevalence of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other conditions that require stent implantation. Factors such as a sedentary lifestyle, poor dietary habits, and the aging population contribute to this high incidence. And also the region has been at the forefront of technological advancements in the field of medical devices, including intravascular stents. Many leading stent manufacturers and research institutions are in the region, driving innovation and product development. North American healthcare systems tend to adopt new medical technologies and treatments relatively early, contributing to a larger market share for innovative stent products, such as drug-eluting stents and bioresorbable stents. The presence of well-established health insurance systems in North America helps patients access and afford stent procedures. This insurance coverage encourages the adoption of stents as a treatment option.

Key Market Players

Boston Scientific Corporation

Medtronic plc.

Terumo Medical Corporation

Abbott Laboratories Inc.

BIOTRONIK SE & Co. KG

Stryker Corporation

Microport Scientific Corporation

Stentys S.A.

HELLMAN & FRIEDMAN LLC

B. Braun SE

Report Scope:

In this report, the Global Intravascular Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravascular Stents Market, By Type:

Drug Eluting Stents Bare Metal Stents Bioabsorbable Stents

Intravascular Stents Market, By Product:

Coronary Stents Peripheral Stents

Intravascular Stents Market, By End-Use:

Hospitals & Clinics Ambulatory Surgical Centers Others

Intravascular Stents Market, By Region:

United States
Canada
Mexico

China
India
South Korea
Australia
Japan

Germany
France
United Kingdom
Spain
Italy

Brazil
Argentina
Colombia

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Intravascular Stents Market.

Available Customizations:

Global Intravascular Stents Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravascular Stents Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
- 5.2.2. By Product (Coronary Stents, Peripheral Stents)
- 5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2023)
5.3. Market Map

6. Asia Pacific Intravascular Stents Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Product
- 6.2.3. By End-Use
- 6.2.4. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Intravascular Stents Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Product
    - 6.3.1.2.3. By End-Use
- 6.3.2. India Intravascular Stents Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Product
    - 6.3.2.2.3. By End-Use
- 6.3.3. Australia Intravascular Stents Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Product
    - 6.3.3.2.3. By End-Use
- 6.3.4. Japan Intravascular Stents Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By Product
    - 6.3.4.2.3. By End-Use
- 6.3.5. South Korea Intravascular Stents Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By Product
    - 6.3.5.2.3. By End-Use

7. Europe Intravascular Stents Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Product
- 7.2.3. By End-Use
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Intravascular Stents Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Product
    - 7.3.1.2.3. By End-Use
- 7.3.2. Germany Intravascular Stents Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Product
    - 7.3.2.2.3. By End-Use
- 7.3.3. Spain Intravascular Stents Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Product
    - 7.3.3.2.3. By End-Use
- 7.3.4. Italy Intravascular Stents Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Product
    - 7.3.4.2.3. By End-Use
- 7.3.5. United Kingdom Intravascular Stents Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Product
    - 7.3.5.2.3. By End-Use

8. North America Intravascular Stents Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Product
- 8.2.3. By End-Use
- 8.2.4. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Intravascular Stents Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Product
    - 8.3.1.2.3. By End-Use
- 8.3.2. Mexico Intravascular Stents Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Product
    - 8.3.2.2.3. By End-Use
- 8.3.3. Canada Intravascular Stents Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Product
    - 8.3.3.2.3. By End-Use

9. South America Intravascular Stents Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Product
- 9.2.3. By End-Use
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Intravascular Stents Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Product
    - 9.3.1.2.3. By End-Use
- 9.3.2. Argentina Intravascular Stents Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Product
    - 9.3.2.2.3. By End-Use
- 9.3.3. Colombia Intravascular Stents Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Product
    - 9.3.3.2.3. By End-Use

10. Middle East and Africa Intravascular Stents Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Product
- 10.2.3. By End-Use
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Intravascular Stents Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Product
    - 10.3.1.2.3. By End-Use
- 10.3.2. Saudi Arabia Intravascular Stents Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Product
    - 10.3.2.2.3. By End-Use
- 10.3.3. UAE Intravascular Stents Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Product
    - 10.3.3.2.3. By End-Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Intravascular Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

16.1. Boston Scientific Corporation
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (In case of listed companies)
- 16.1.5. Recent Developments
- 16.1.6. SWOT Analysis
16.2. Medtronic plc.
16.3. Terumo Medical Corporation
16.4. Abbott Laboratories Inc.
16.5. BIOTRONIK SE & Co. KG
16.6. Stryker Corporation
16.7. Microport Scientific Corporation
16.8. Stentys S.A.
16.9. HELLMAN & FRIEDMAN LLC
16.10.B. Braun SE